Logo image of GTLB

GITLAB INC-CL A (GTLB) Stock Fundamental Analysis

USA - NASDAQ:GTLB - US37637K1088 - Common Stock

50.2 USD
+0.16 (+0.32%)
Last: 9/19/2025, 8:14:29 PM
50.16 USD
-0.04 (-0.08%)
After Hours: 9/19/2025, 8:14:29 PM
Fundamental Rating

5

GTLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. No worries on liquidiy or solvency for GTLB as it has an excellent financial health rating, but there are worries on the profitability. GTLB is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

GTLB had positive earnings in the past year.
GTLB had a positive operating cash flow in the past year.
In the past 5 years GTLB always reported negative net income.
In the past 5 years GTLB reported 4 times negative operating cash flow.
GTLB Yearly Net Income VS EBIT VS OCF VS FCFGTLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M

1.2 Ratios

GTLB has a Return On Assets (-0.65%) which is comparable to the rest of the industry.
GTLB has a Return On Equity (-1.12%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.65%
ROE -1.12%
ROIC N/A
ROA(3y)-15.83%
ROA(5y)-22.94%
ROE(3y)-33.12%
ROE(5y)-43.72%
ROIC(3y)N/A
ROIC(5y)N/A
GTLB Yearly ROA, ROE, ROICGTLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

GTLB has a Gross Margin of 88.52%. This is amongst the best in the industry. GTLB outperforms 94.64% of its industry peers.
GTLB's Gross Margin has been stable in the last couple of years.
GTLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.25%
GM growth 5Y0.07%
GTLB Yearly Profit, Operating, Gross MarginsGTLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

8

2. Health

2.1 Basic Checks

GTLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
GTLB has more shares outstanding than it did 1 year ago.
GTLB has more shares outstanding than it did 5 years ago.
There is no outstanding debt for GTLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GTLB Yearly Shares OutstandingGTLB Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M
GTLB Yearly Total Debt VS Total AssetsGTLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

GTLB has an Altman-Z score of 7.85. This indicates that GTLB is financially healthy and has little risk of bankruptcy at the moment.
GTLB has a Altman-Z score of 7.85. This is in the better half of the industry: GTLB outperforms 78.93% of its industry peers.
GTLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.85
ROIC/WACCN/A
WACC11.1%
GTLB Yearly LT Debt VS Equity VS FCFGTLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.60 indicates that GTLB has no problem at all paying its short term obligations.
The Current ratio of GTLB (2.60) is better than 72.14% of its industry peers.
GTLB has a Quick Ratio of 2.60. This indicates that GTLB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.60, GTLB is in the better half of the industry, outperforming 72.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 2.6
GTLB Yearly Current Assets VS Current LiabilitesGTLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

7

3. Growth

3.1 Past

GTLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 130.95%, which is quite impressive.
GTLB shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.97%.
Measured over the past years, GTLB shows a very strong growth in Revenue. The Revenue has been growing by 56.36% on average per year.
EPS 1Y (TTM)130.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)28.97%
Revenue growth 3Y44.31%
Revenue growth 5Y56.36%
Sales Q2Q%29.23%

3.2 Future

Based on estimates for the next years, GTLB will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.09% on average per year.
The Revenue is expected to grow by 19.31% on average over the next years. This is quite good.
EPS Next Y3.79%
EPS Next 2Y13.8%
EPS Next 3Y18.94%
EPS Next 5Y16.09%
Revenue Next Year24.82%
Revenue Next 2Y22.45%
Revenue Next 3Y21.4%
Revenue Next 5Y19.31%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GTLB Yearly Revenue VS EstimatesGTLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
GTLB Yearly EPS VS EstimatesGTLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 51.75, GTLB can be considered very expensive at the moment.
GTLB's Price/Earnings is on the same level as the industry average.
GTLB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.38.
Based on the Price/Forward Earnings ratio of 52.38, the valuation of GTLB can be described as expensive.
GTLB's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of GTLB to the average of the S&P500 Index (22.86), we can say GTLB is valued expensively.
Industry RankSector Rank
PE 51.75
Fwd PE 52.38
GTLB Price Earnings VS Forward Price EarningsGTLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

GTLB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 233.52
EV/EBITDA N/A
GTLB Per share dataGTLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GTLB does not grow enough to justify the current Price/Earnings ratio.
GTLB's earnings are expected to grow with 18.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)13.65
PEG (5Y)N/A
EPS Next 2Y13.8%
EPS Next 3Y18.94%

More info and screens

0

5. Dividend

5.1 Amount

GTLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GITLAB INC-CL A

NASDAQ:GTLB (9/19/2025, 8:14:29 PM)

After market: 50.16 -0.04 (-0.08%)

50.2

+0.16 (+0.32%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-03 2025-09-03/amc
Earnings (Next)12-05 2025-12-05/amc
Inst Owners89.66%
Inst Owner Change-5.52%
Ins Owners3.85%
Ins Owner Change2.98%
Market Cap8.37B
Analysts81.71
Price Target59.49 (18.51%)
Short Float %9.63%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.47%
Min EPS beat(2)11.5%
Max EPS beat(2)43.44%
EPS beat(4)4
Avg EPS beat(4)35.7%
Min EPS beat(4)11.5%
Max EPS beat(4)45.23%
EPS beat(8)8
Avg EPS beat(8)196.89%
EPS beat(12)12
Avg EPS beat(12)156.92%
EPS beat(16)16
Avg EPS beat(16)126.43%
Revenue beat(2)1
Avg Revenue beat(2)0.23%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)1.8%
Revenue beat(4)3
Avg Revenue beat(4)0.82%
Min Revenue beat(4)-1.34%
Max Revenue beat(4)2.27%
Revenue beat(8)6
Avg Revenue beat(8)1.21%
Revenue beat(12)10
Avg Revenue beat(12)2.16%
Revenue beat(16)14
Avg Revenue beat(16)3.79%
PT rev (1m)-5.75%
PT rev (3m)-19.56%
EPS NQ rev (1m)5.24%
EPS NQ rev (3m)7.05%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)5.01%
Revenue NQ rev (1m)-0.79%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.19%
Valuation
Industry RankSector Rank
PE 51.75
Fwd PE 52.38
P/S 9.75
P/FCF 233.52
P/OCF 199.89
P/B 9.66
P/tB 10.01
EV/EBITDA N/A
EPS(TTM)0.97
EY1.93%
EPS(NY)0.96
Fwd EY1.91%
FCF(TTM)0.21
FCFY0.43%
OCF(TTM)0.25
OCFY0.5%
SpS5.15
BVpS5.2
TBVpS5.02
PEG (NY)13.65
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.65%
ROE -1.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.52%
FCFM 4.18%
ROA(3y)-15.83%
ROA(5y)-22.94%
ROE(3y)-33.12%
ROE(5y)-43.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.25%
GM growth 5Y0.07%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 53.67%
Cap/Sales 0.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.6
Quick Ratio 2.6
Altman-Z 7.85
F-Score6
WACC11.1%
ROIC/WACCN/A
Cap/Depr(3y)55.75%
Cap/Depr(5y)176.13%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)130.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y3.79%
EPS Next 2Y13.8%
EPS Next 3Y18.94%
EPS Next 5Y16.09%
Revenue 1Y (TTM)28.97%
Revenue growth 3Y44.31%
Revenue growth 5Y56.36%
Sales Q2Q%29.23%
Revenue Next Year24.82%
Revenue Next 2Y22.45%
Revenue Next 3Y21.4%
Revenue Next 5Y19.31%
EBIT growth 1Y41.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.43%
EBIT Next 3Y52.78%
EBIT Next 5Y40.27%
FCF growth 1Y26067.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1195.73%
OCF growth 3YN/A
OCF growth 5YN/A